Date published: 2025-9-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

Chenodeoxycholic Acid 24-Acyl-β-D-glucuronide (CAS 208038-27-1)

0.0(0)
Write a reviewAsk a question

Alternate Names:
Chenodeoxycholic Acid 24-Acyl-β-D-glucuronide; 1-[(3α,5β,7α)-3,7-Dihydroxycholan-24-oate] β-D-Glucopyranuronic Acid
CAS Number:
208038-27-1
Molecular Weight:
568.7
Molecular Formula:
C30H48O10
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Chenodeoxycholic Acid 24-Acyl-β-D-glucuronide is a chemically modified derivative of chenodeoxycholic acid, featuring an acyl substitution at the 24th carbon and a β-D-glucuronide moiety. This modification introduces a glucuronic acid component, which is linked through a glycosidic bond, enhancing the compound′s solubility and altering its interaction with biological systems. The structural alteration facilitates the study of bile acid metabolism and transport mechanisms by providing a compound with distinct physicochemical properties. This derivative is particularly useful in research applications for exploring the pathways and biological effects of bile acids and their derivatives, focusing on their role in biochemical processes


Chenodeoxycholic Acid 24-Acyl-β-D-glucuronide (CAS 208038-27-1) References

  1. In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions.  |  Lee, SJ., et al. 2015. Toxicol Lett. 232: 458-65. PMID: 25448279
  2. Expression of hepatic cytochrome P450s and UDP-glucuronosyltransferases in PXR and CAR double humanized mice treated with rifampicin.  |  Lee, SY., et al. 2015. Toxicol Lett. 235: 107-15. PMID: 25835148
  3. CYP3A Specifically Catalyzes 1β-Hydroxylation of Deoxycholic Acid: Characterization and Enzymatic Synthesis of a Potential Novel Urinary Biomarker for CYP3A Activity.  |  Hayes, MA., et al. 2016. Drug Metab Dispos. 44: 1480-9. PMID: 27402728
  4. In vitro stereoselective inhibition of ginsenosides toward UDP-glucuronosyltransferase (UGT) isoforms.  |  Kim, D., et al. 2016. Toxicol Lett. 259: 1-10. PMID: 27462006
  5. In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions.  |  Zheng, YF., et al. 2016. Molecules. 21: PMID: 27529203
  6. Single-shot multi-reaction monitoring of intact marker conjugates for quantitative profiling of human major microsomal glucuronidations and its utility to screen inhibitors from medicinal herbs.  |  Cheng, Y., et al. 2016. Anal Bioanal Chem. 408: 8117-8132. PMID: 27604270
  7. Design and optimization of the cocktail assay for rapid assessment of the activity of UGT enzymes in human and rat liver microsomes.  |  Chen, A., et al. 2018. Toxicol Lett. 295: 379-389. PMID: 30036684
  8. Evaluation of the inhibition risk of shikonin on human and rat UDP-glucuronosyltransferases (UGT) through the cocktail approach.  |  Cheng, Y., et al. 2019. Toxicol Lett. 312: 214-221. PMID: 31128210
  9. Metabolomics analysis delineates the therapeutic effects of Huangqi decoction and astragalosides on α-naphthylisothiocyanate (ANIT) -induced cholestasis in rats.  |  Qiu, J., et al. 2021. J Ethnopharmacol. 268: 113658. PMID: 33307056
  10. UGT1A1 and UGT1A3 activity and inhibition in human liver and intestinal microsomes and a recombinant UGT system under similar assay conditions using selective substrates and inhibitors.  |  Mullapudi, TVR., et al. 2021. Xenobiotica. 51: 1236-1246. PMID: 34698602
  11. Contributions of UDP-Glucuronosyltransferases to Human Hepatic and Intestinal Metabolism of Ticagrelor and Inhibition of UGTs and Cytochrome P450 Enzymes by Ticagrelor and its Glucuronidated Metabolite.  |  Liu, S., et al. 2021. Front Pharmacol. 12: 761814. PMID: 34721047
  12. Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions.  |  Liu, S., et al. 2022. Chem Biol Interact. 352: 109775. PMID: 34910929
  13. Effect of lotus seed resistant starch on small intestinal flora and bile acids in hyperlipidemic rats.  |  Lei, S., et al. 2023. Food Chem. 404: 134599. PMID: 36444019
  14. Biotransformation of Penindolone, an Influenza A Virus Inhibitor.  |  Liu, S., et al. 2023. Molecules. 28: PMID: 36771146
  15. Serum Bile Acid Metabolites Predict the Therapeutic Effect of Mesalazine in Patients with Ulcerative Colitis.  |  Sun, Q., et al. 2023. J Proteome Res. 22: 1287-1297. PMID: 36921116

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Chenodeoxycholic Acid 24-Acyl-β-D-glucuronide, 2.5 mg

sc-504781
2.5 mg
$337.00